69 related articles for article (PubMed ID: 552256)
1. [Experimental study of the hypolipidemic effect of tiadenol].
Accarino G; Barone L; Chieppa S; Giusti I; Nutile T; Luppino E; Visone C
Boll Chim Farm; 1979 Dec; 118(12):739-47. PubMed ID: 552256
[No Abstract] [Full Text] [Related]
2. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats. II. Comparative action of clofibrate and tiadenol on biliary and fecal excretion of cholesterol and its metabolites in rats].
Fredj G; Clenet M; Rousselet F
Ann Pharm Fr; 1986; 44(5):347-54. PubMed ID: 3579157
[No Abstract] [Full Text] [Related]
3. Experimental studies on pharmacology, metabolism and toxicology with tiadenol-disulfoxide. Dissociation of lipid lowering effects and the induction of peroxisomal and microsomal drug-metabolizing enzymes.
Maffei Facino R; Carini M; Tofanetti O; Casciarri I; Longoni E
Arzneimittelforschung; 1987 Jun; 37(6):682-91. PubMed ID: 3663266
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the citrate ion and tiadenol on the physico-chemical balance of the bile].
Rozé C; Vaille C; Souchard M; de la Tour J; Debray C
Med Chir Dig; 1975; 4 Suppl 1():61-5. PubMed ID: 1230598
[No Abstract] [Full Text] [Related]
5. [The effect of tiadenol on type IIA hyperlipidemias].
de Gennes JL; Truffert J; Le Quere JM
Therapie; 1976; 31(4):455-63. PubMed ID: 188209
[No Abstract] [Full Text] [Related]
6. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
Passeri M; Cocchi C; Ceccato S; Palummeri E; Cucinotta D
G Clin Med; 1979 Jan; 60(1):49-64. PubMed ID: 456778
[No Abstract] [Full Text] [Related]
7. [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)].
Rouffy J
Therapie; 1975; 30(6):815-23. PubMed ID: 785682
[No Abstract] [Full Text] [Related]
8. Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.
Cuchet P; Morrier C; Cand F; Keriel C
Lipids; 1981 Oct; 16(10):732-8. PubMed ID: 7300592
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
Saettone G; Cazzani E; Romanò M; Muzio L
Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643
[No Abstract] [Full Text] [Related]
10. Effects of citrate and tiadenol on physicochemical equilibrium of bile in rats.
Rozé C; Vaille C; Souchard M; de La Tour J; Debray C
Digestion; 1975; 12(2):114-7. PubMed ID: 1158066
[TBL] [Abstract][Full Text] [Related]
11. [Inducing effects of bis-hydroxyethylthio-1,10-decane (tiadenol) on hepatic microsomal enzymes of the rat].
Mounie J; Goudonnet H; Bereksi-Reguig K; Escousse A; Truchot R
J Pharmacol; 1983; 14(2):171-82. PubMed ID: 6408317
[TBL] [Abstract][Full Text] [Related]
12. [Hypolipidemic activity of glycine and its derivatives].
Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
[TBL] [Abstract][Full Text] [Related]
13. [Hypolipidemic properties of triterpenoids].
Vasilenko IuK; Lisevitskaia LI; Frolova LM; Parfent'eva EP; Skul'te IV
Farmakol Toksikol; 1982; 45(5):66-70. PubMed ID: 7140959
[TBL] [Abstract][Full Text] [Related]
14. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].
Ryzhenkov VE; Chistiakova AM; Okunevich IV
Patol Fiziol Eksp Ter; 1989; (5):16-9. PubMed ID: 2616207
[TBL] [Abstract][Full Text] [Related]
15. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].
Cucinotta D; Palummeri E; Ceccato S; Passeri M
G Ital Cardiol; 1977; 7(3):248-64. PubMed ID: 858465
[TBL] [Abstract][Full Text] [Related]
16. Hypolipidemic effect of Coriandrum sativum L. in triton-induced hyperlipidemic rats.
Lal AA; Kumar T; Murthy PB; Pillai KS
Indian J Exp Biol; 2004 Sep; 42(9):909-12. PubMed ID: 15462185
[TBL] [Abstract][Full Text] [Related]
17. [Experimental hypolipidemic and antiatherosclerotic activity of bisanions].
Ryzhenkov VE; Khromov-Borisov NV; Mosina IV; Indenbom ML
Farmakol Toksikol; 1979; 42(6):632-5. PubMed ID: 499472
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on the antilipemic effect of tiadenol (Eulip)].
Peduzzi L; Cozzi E
Minerva Med; 1983 Feb; 74(6):249-54. PubMed ID: 6338419
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of substances with antihypoxic action in experimental hyperlipidemia].
Ryzhenkov VE; Remezova OV; Triufanov VF; Vasil'eva LE
Eksp Klin Farmakol; 1992; 55(5):39-41. PubMed ID: 1305449
[TBL] [Abstract][Full Text] [Related]
20. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh
Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
